Orbimed Advisors LLC Morphic Holding, Inc. Transaction History
Orbimed Advisors LLC
- $4.15 Billion
- Q2 2024
A detailed history of Orbimed Advisors LLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 612,500 shares of MORF stock, worth $34.9 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
612,500
Previous 558,500
9.67%
Holding current value
$34.9 Million
Previous $19.7 Million
6.14%
% of portfolio
0.5%
Previous 0.44%
Shares
4 transactions
Others Institutions Holding MORF
# of Institutions
140Shares Held
38.7MCall Options Held
4.2KPut Options Held
200K-
Wellington Management Group LLP Boston, MA5.81MShares$331 Million0.04% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.98MShares$284 Million6.0% of portfolio
-
Black Rock Inc. New York, NY3.53MShares$201 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N42.53MShares$144 Million5.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.22MShares$126 Million0.0% of portfolio
About Morphic Holding, Inc.
- Ticker MORF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,477,100
- Market Cap $2.19B
- Description
- Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...